SK Biopharmaceuticals Co Ltd
KRX:326030
SK Biopharmaceuticals Co Ltd
KRX:326030
Price:
104 300
KRW
1.07%
Market Closed
Market Cap:
8.2T
KRW
Cash Flow Statement
Cash Flow Statement
SK Biopharmaceuticals Co Ltd
SK Biopharmaceuticals Co Ltd
Currency: KRW
Millions
TTM
| Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Net Income |
(71 519)
|
(210 214)
|
(229 536)
|
(242 366)
|
(247 414)
|
(51 828)
|
(59 196)
|
(40 396)
|
64 846
|
(99 351)
|
(77 756)
|
(48 445)
|
(139 431)
|
(106 594)
|
(84 533)
|
(87 985)
|
(35 379)
|
(23 313)
|
24 588
|
49 310
|
226 973
|
|
| Depreciation & Amortization |
6 501
|
7 140
|
7 859
|
9 488
|
10 859
|
11 646
|
12 168
|
11 844
|
11 642
|
11 870
|
12 160
|
12 568
|
12 984
|
13 301
|
13 604
|
14 222
|
15 317
|
16 309
|
17 132
|
17 459
|
17 428
|
|
| Other Non-Cash Items |
(9 214)
|
(8 851)
|
(6 707)
|
(8 898)
|
15 110
|
13 795
|
23 517
|
13 478
|
(95 838)
|
(94 173)
|
(101 543)
|
(86 481)
|
35 848
|
13 734
|
9 173
|
12 193
|
5 643
|
27 853
|
39 624
|
39 161
|
(105 692)
|
|
| Cash Taxes Paid |
708
|
722
|
432
|
317
|
6 389
|
6 548
|
7 840
|
11 946
|
6 160
|
9 191
|
6 369
|
4 118
|
4 681
|
1 804
|
7 735
|
7 206
|
8 126
|
8 203
|
10 475
|
12 604
|
12 154
|
|
| Cash Interest Paid |
1 234
|
2 165
|
4 131
|
4 540
|
4 441
|
3 710
|
1 838
|
1 225
|
844
|
832
|
1 012
|
2 053
|
3 488
|
5 006
|
6 436
|
7 423
|
8 142
|
8 458
|
9 297
|
9 528
|
9 499
|
|
| Change in Working Capital |
(6 694)
|
5 841
|
(19 015)
|
(28 111)
|
7 465
|
(158 645)
|
(139 940)
|
(18 762)
|
(73 521)
|
68 180
|
70 946
|
(66 636)
|
(69 321)
|
(71 901)
|
(79 706)
|
(58 330)
|
(79 782)
|
(48 092)
|
(88 093)
|
(86 191)
|
(43 809)
|
|
| Cash from Operating Activities |
(80 926)
N/A
|
(206 085)
-155%
|
(247 399)
-20%
|
(269 888)
-9%
|
(213 980)
+21%
|
(185 031)
+14%
|
(163 450)
+12%
|
(33 834)
+79%
|
(92 872)
-174%
|
(113 474)
-22%
|
(96 193)
+15%
|
(188 994)
-96%
|
(159 920)
+15%
|
(151 460)
+5%
|
(141 462)
+7%
|
(119 901)
+15%
|
(94 201)
+21%
|
(27 243)
+71%
|
(6 749)
+75%
|
19 738
N/A
|
94 900
+381%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
(14 048)
|
(13 869)
|
(12 966)
|
(14 025)
|
(14 336)
|
(15 232)
|
(12 117)
|
(8 359)
|
(5 992)
|
(5 299)
|
(6 162)
|
(5 825)
|
(5 961)
|
(6 206)
|
(5 084)
|
(4 648)
|
(3 249)
|
(2 700)
|
(2 241)
|
(13 719)
|
(13 424)
|
|
| Other Items |
(25 417)
|
38 726
|
(59 159)
|
(272 211)
|
(304 394)
|
(168 931)
|
(69 960)
|
199 280
|
264 963
|
63 697
|
41 863
|
(95 417)
|
(89 753)
|
2 998
|
59 942
|
284 420
|
228 522
|
182 243
|
149 954
|
2 739
|
2 484
|
|
| Cash from Investing Activities |
(39 465)
N/A
|
24 857
N/A
|
(72 126)
N/A
|
(286 235)
-297%
|
(318 730)
-11%
|
(184 163)
+42%
|
(82 077)
+55%
|
190 920
N/A
|
258 971
+36%
|
58 397
-77%
|
35 701
-39%
|
(101 242)
N/A
|
(95 714)
+5%
|
(3 208)
+97%
|
54 857
N/A
|
279 772
+410%
|
225 273
-19%
|
179 542
-20%
|
147 713
-18%
|
(10 979)
N/A
|
(10 941)
+0%
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
645 465
|
645 465
|
645 465
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
97 241
|
196 878
|
196 114
|
(54 529)
|
(104 562)
|
(204 901)
|
(204 618)
|
(54 705)
|
(4 827)
|
36 818
|
36 679
|
136 522
|
136 274
|
94 449
|
94 366
|
(5 558)
|
(5 575)
|
19 453
|
19 806
|
(4 884)
|
(4 498)
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
6
|
(6)
|
86
|
181
|
(464)
|
(439)
|
(529)
|
(1 360)
|
0
|
(684)
|
19 833
|
12 198
|
0
|
12 147
|
(8 372)
|
0
|
|
| Cash from Financing Activities |
97 241
N/A
|
196 878
+102%
|
841 579
+327%
|
590 936
-30%
|
540 902
-8%
|
440 569
-19%
|
(204 624)
N/A
|
(54 619)
+73%
|
(4 646)
+91%
|
36 354
N/A
|
36 240
0%
|
135 993
+275%
|
134 914
-1%
|
93 729
-31%
|
93 683
0%
|
14 275
-85%
|
6 623
-54%
|
31 651
+378%
|
31 953
+1%
|
(13 256)
N/A
|
(4 498)
+66%
|
|
| Change in Cash | ||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
732
|
1 706
|
(68)
|
0
|
2 054
|
1 144
|
4 721
|
5 135
|
5 287
|
10 065
|
16 503
|
(1 143)
|
(6 663)
|
(13 487)
|
(18 199)
|
(2 054)
|
1 980
|
5 503
|
(865)
|
3 646
|
|
| Net Change in Cash |
(23 150)
N/A
|
16 382
N/A
|
523 760
+3 097%
|
34 745
-93%
|
8 192
-76%
|
73 429
+796%
|
(449 007)
N/A
|
107 188
N/A
|
166 589
+55%
|
(13 436)
N/A
|
(14 187)
-6%
|
(137 739)
-871%
|
(121 863)
+12%
|
(67 602)
+45%
|
(6 409)
+91%
|
155 947
N/A
|
135 640
-13%
|
185 931
+37%
|
178 419
-4%
|
(5 361)
N/A
|
83 107
N/A
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
(94 974)
N/A
|
(219 954)
-132%
|
(260 365)
-18%
|
(283 913)
-9%
|
(228 317)
+20%
|
(200 263)
+12%
|
(175 567)
+12%
|
(42 193)
+76%
|
(98 864)
-134%
|
(118 773)
-20%
|
(102 355)
+14%
|
(194 819)
-90%
|
(165 881)
+15%
|
(157 666)
+5%
|
(146 546)
+7%
|
(124 549)
+15%
|
(97 451)
+22%
|
(29 943)
+69%
|
(8 990)
+70%
|
6 020
N/A
|
81 476
+1 253%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
